Using Receptor Architecture to Improve CAR-T Cell Sensitivity in Oncology (ASGCT 2024)
PharmaTech
MAY 11, 2024
Phillip Gregory, PhD, senior vice-president and head of Regeneron Cell Medicines, Regeneron, discussed how engineering receptor architecture can be a tool to improve CAR-T cell sensitivity to tumor antigens.
Let's personalize your content